Patient ranking

Preliminary disease

(Payer-based DB ) July 2020 to June 2021

Name

Number of patients diagnosed

  1. J30 Vasomotor and allergic rhinitis <Nasal allergy> 2,179,381
  2. E78 Lipoprotein <Protein> Metabolic disorders and other lipemias 908,162
  3. L20 Atopic dermatitis 572,764
  4. E10-E14 Diabetes mellitus 491,560
  5. H40 Glaucoma 308,602
  6. D50 Iron deficiency anemia 289,267
  7. F32 Depressive episodes 277,315
  8. G43 Migraine 132,025
  9.              
  10. H26 Other cataracts 129,670

*Number of unique patients with at least 1 diagnosis/prescription during the period

Autoimmune disease

(Payer-based DB ) July 2020 to June 2021

Name

Number of patients diagnosed

  1. M06 Other rheumatoid arthritis 56,351
  2. L40 Psoriasis <Tinea> 41,715
  3. K51 Ulcerative colitis 25,735
  4. M32 Systemic lupus erythematosus <systemic lupus erythematosus> <SLE> 11,744
  5. K50 Crohn’s disease [regional enteritis] 5,600

*Number of unique patients with at least 1 diagnosis/prescription during the period

Biologic drugs

(Payer-based DB) July 2020 to June 2021

Name

Number of patients prescribed

  1. Humira (L04B-) 2,935
  2. Dupixent (L04C-) 2,669
  3. Remicade (L04B-) 2,473
  4. Actemra (M01C-) 2,379
  5. Simponi (L04B-) 1,127
  6. Enbrel (L04B-) 1,123
  7. Orencia (M01C-) 726
  8. Cimzia (L04B-) 541
  9. Kevzara (M01C-) 260

*Number of unique patients with at least 1 diagnosis/prescription during the period

Female disease

(Payer-based DB) July 2020 to June 2021

Name

Number of patients diagnosed

  1. D25 Uterine leiomyoma 161,161
  2. N92 Menorrhagia, polymenorrhea, and menstrual irregularity 95,900
  3. N80 Endometriosis 93,978
  4. C50 Malignant breast neoplasm <Tumor> 44,968
  5. C53 Malignant neoplasm of the uterine cervix <Tumor> 5,702
  6. C56 Malignant neoplasm of the ovary <Tumor> 5,255

*Number of unique patients with at least 1 diagnosis/prescription during the period